KPTI
Price
$6.81
Change
-$0.67 (-8.96%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
64.86M
PGEN
Price
$3.85
Change
+$0.15 (+4.04%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.31B
49 days until earnings call
Interact to see
Advertisement

KPTI vs PGEN

Header iconKPTI vs PGEN Comparison
Open Charts KPTI vs PGENBanner chart's image
Karyopharm Therapeutics
Price$6.81
Change-$0.67 (-8.96%)
Volume$200
Capitalization64.86M
Precigen
Price$3.85
Change+$0.15 (+4.04%)
Volume$104.21K
Capitalization1.31B
KPTI vs PGEN Comparison Chart in %
Loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPTI vs. PGEN commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a Hold and PGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (KPTI: $7.48 vs. PGEN: $3.71)
Brand notoriety: KPTI and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPTI: 295% vs. PGEN: 58%
Market capitalization -- KPTI: $64.86M vs. PGEN: $1.31B
KPTI [@Biotechnology] is valued at $64.86M. PGEN’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPTI’s FA Score shows that 1 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • KPTI’s FA Score: 1 green, 4 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, KPTI is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPTI’s TA Score shows that 4 TA indicator(s) are bullish while PGEN’s TA Score has 4 bullish TA indicator(s).

  • KPTI’s TA Score: 4 bullish, 4 bearish.
  • PGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KPTI and PGEN are a good buy in the short-term.

Price Growth

KPTI (@Biotechnology) experienced а +19.49% price change this week, while PGEN (@Biotechnology) price change was -4.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

PGEN is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($1.31B) has a higher market cap than KPTI($64.9M). PGEN YTD gains are higher at: 231.250 vs. KPTI (-26.265). KPTI has higher annual earnings (EBITDA): -78.44M vs. PGEN (-121.98M). PGEN has more cash in the bank: 59.8M vs. KPTI (51.7M). PGEN has less debt than KPTI: PGEN (5.15M) vs KPTI (191M). KPTI has higher revenues than PGEN: KPTI (137M) vs PGEN (4.34M).
KPTIPGENKPTI / PGEN
Capitalization64.9M1.31B5%
EBITDA-78.44M-121.98M64%
Gain YTD-26.265231.250-11%
P/E RatioN/AN/A-
Revenue137M4.34M3,157%
Total Cash51.7M59.8M86%
Total Debt191M5.15M3,707%
FUNDAMENTALS RATINGS
KPTI vs PGEN: Fundamental Ratings
KPTI
PGEN
OUTLOOK RATING
1..100
7056
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5735
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (5) in the Biotechnology industry is significantly better than the same rating for PGEN (71) in the null industry. This means that KPTI’s stock grew significantly faster than PGEN’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that KPTI’s stock grew similarly to PGEN’s over the last 12 months.

KPTI's SMR Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that KPTI’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's Price Growth Rating (35) in the null industry is in the same range as KPTI (57) in the Biotechnology industry. This means that PGEN’s stock grew similarly to KPTI’s over the last 12 months.

PGEN's P/E Growth Rating (100) in the null industry is in the same range as KPTI (100) in the Biotechnology industry. This means that PGEN’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPTIPGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 29 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYSDY10.950.72
+7.07%
Lynas Rare Earths Limited
KSRYY8.100.17
+2.14%
Kose Corp.
NVLPF0.24N/A
N/A
Nova Leap Health Corp.
TVBCY1.00N/A
N/A
Television Broadcasts Ltd.
AILIO70.00N/A
N/A
Ameren Illinois Company

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with MGNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
+27.86%
MGNX - KPTI
40%
Loosely correlated
-4.05%
PGEN - KPTI
38%
Loosely correlated
-3.64%
XENE - KPTI
32%
Poorly correlated
-0.11%
XNCR - KPTI
32%
Poorly correlated
-0.67%
PDSB - KPTI
32%
Poorly correlated
-2.78%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with ZNTL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-3.64%
ZNTL - PGEN
40%
Loosely correlated
-1.32%
XENE - PGEN
39%
Loosely correlated
-0.11%
MRNA - PGEN
38%
Loosely correlated
-2.90%
KPTI - PGEN
38%
Loosely correlated
+27.86%
SYRE - PGEN
38%
Loosely correlated
+4.77%
More